Detalles de la búsqueda
1.
Discovery of (E)-5-(benzylideneamino)-1H-benzo[d]imidazol-2(3H)-one derivatives as inhibitors for PTK6.
Bioorg Med Chem Lett
; 24(19): 4659-4663, 2014 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25205190
2.
The presence of outer arm fucose residues on the N-glycans of tissue inhibitor of metalloproteinases-1 reduces its activity.
J Proteome Res
; 12(8): 3547-60, 2013 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-23815085
3.
The associated pyrazolopyrimidines PP1 and PP2 inhibit protein tyrosine kinase 6 activity and suppress breast cancer cell proliferation.
Oncol Lett
; 13(3): 1463-1469, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28454278
4.
Growth-stimulatory activity of TIMP-2 is mediated through c-Src activation followed by activation of FAK, PI3-kinase/AKT, and ERK1/2 independent of MMP inhibition in lung adenocarcinoma cells.
Oncotarget
; 6(40): 42905-22, 2015 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26556867
5.
Molecular dissection of the interaction between the SH3 domain and the SH2-Kinase Linker region in PTK6.
Biochem Biophys Res Commun
; 362(4): 829-34, 2007 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-17822667
6.
An intramolecular interaction between SH2-kinase linker and kinase domain is essential for the catalytic activity of protein-tyrosine kinase-6.
J Biol Chem
; 280(32): 28973-80, 2005 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-15961400
7.
Solution structure and backbone dynamics of the non-receptor protein-tyrosine kinase-6 Src homology 2 domain.
J Biol Chem
; 279(28): 29700-8, 2004 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-15056653
Resultados
1 -
7
de 7
1
Próxima >
>>